Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia (Q43217991)

16 November 2017

Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia (English)

1 reference

16 November 2017

1 reference

D-C Liang

1

1 reference

16 November 2017

C-P Yang

2

1 reference

16 November 2017

D-T Lin

3

1 reference

16 November 2017

I-J Hung

4

1 reference

16 November 2017

K-H Lin

5

1 reference

16 November 2017

J-S Chen

6

1 reference

16 November 2017

C-C Hsiao

7

1 reference

16 November 2017

T-T Chang

8

1 reference

16 November 2017

C-T Peng

9

1 reference

16 November 2017

M-T Lin

10

1 reference

16 November 2017

T-K Chang

11

1 reference

16 November 2017

T-H Jaing

12

1 reference

16 November 2017

H-C Liu

13

1 reference

16 November 2017

L-Y Wang

14

1 reference

16 November 2017

T-C Yeh

15

1 reference

16 November 2017

S-T Jou

16

1 reference

16 November 2017

M-Y Lu

17

1 reference

16 November 2017

C-N Cheng

18

1 reference

16 November 2017

J-M Sheen

19

1 reference

16 November 2017

S-S Chiou

20

1 reference

16 November 2017

K-H Wu

21

1 reference

16 November 2017

G-Y Hung

22

1 reference

16 November 2017

R-L Chen

23

1 reference

16 November 2017

S-H Chen

24

1 reference

16 November 2017

S-N Cheng

25

1 reference

16 November 2017

Y-H Chang

26

1 reference

16 November 2017

B-W Chen

27

1 reference

16 November 2017

W-L Ho

28

1 reference

16 November 2017

J-L Wang

29

1 reference

16 November 2017

S-T Lin

30

1 reference

16 November 2017

Y-L Hsieh

31

1 reference

16 November 2017

S-C Wang

32

1 reference

16 November 2017

H-H Chang

33

1 reference

16 November 2017

Y-L Yang

34

1 reference

16 November 2017

F-L Huang

35

1 reference

16 November 2017

C-Y Chang

36

1 reference

16 November 2017

W-H Chang

37

1 reference

16 November 2017

K-S Lin

38

1 reference

16 November 2017

language of work or name

1 reference

17 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

24

1 reference

16 November 2017

2

1 reference

16 November 2017

397-405

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2009.248

16 November 2017

0 references

cites work

Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Treating childhood acute lymphoblastic leukemia without cranial irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.248

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.248

1 reference

Dimensions Publication ID

16 November 2017

0 references

1 reference